Trial Profile
Lixiana Acute Stroke Evaluation Registry
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 09 Apr 2024
Price :
$35
*
At a glance
- Drugs Edoxaban (Primary)
- Indications Stroke; Transient ischaemic attacks
- Focus Therapeutic Use
- Acronyms LASER
- 03 Apr 2024 Status changed from recruiting to completed.
- 06 Apr 2022 Planned End Date changed from 31 Dec 2023 to 31 Dec 2024.
- 06 Apr 2022 Planned primary completion date changed from 31 Dec 2022 to 31 Dec 2023.